Total Payments
$231,608
2024 Payments
$6,368
Companies
25
Transactions
368
Payment Breakdown by Category
Other$81,174 (35.0%)
Consulting$65,810 (28.4%)
Research$43,488 (18.8%)
Travel$27,975 (12.1%)
Food & Beverage$13,072 (5.6%)
Education$89.43 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $77,974 | 17 | 33.7% |
| Consulting Fee | $65,810 | 18 | 28.4% |
| Unspecified | $43,488 | 32 | 18.8% |
| Travel and Lodging | $27,975 | 58 | 12.1% |
| Food and Beverage | $13,072 | 240 | 5.6% |
| Honoraria | $3,200 | 1 | 1.4% |
| Education | $89.43 | 2 | 0.0% |
Payments by Type
General
$188,119
336 transactions
Research
$43,488
32 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lumenis, Inc | $59,269 | 6 | $0 (2021) |
| Abbott Laboratories | $50,758 | 30 | $0 (2023) |
| MERZ NORTH AMERICA, INC. | $41,470 | 101 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $32,077 | 17 | $0 (2019) |
| Allergan, Inc. | $16,404 | 81 | $0 (2022) |
| LEO Pharma AS | $9,612 | 3 | $0 (2019) |
| ABBVIE INC. | $9,486 | 63 | $0 (2024) |
| Lumenis BE LTD | $4,500 | 2 | $0 (2022) |
| Galderma Laboratories, L.P. | $3,172 | 19 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $1,958 | 4 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,368 | 30 | ABBVIE INC. ($5,683) |
| 2023 | $17,091 | 56 | Abbott Laboratories ($14,289) |
| 2022 | $38,802 | 37 | Abbott Laboratories ($36,470) |
| 2021 | $7,704 | 19 | Lumenis, Inc ($3,000) |
| 2020 | $10,944 | 9 | Lumenis, Inc ($7,383) |
| 2019 | $65,595 | 77 | Lumenis, Inc ($26,640) |
| 2018 | $40,979 | 59 | Endo Pharmaceuticals Inc. ($21,676) |
| 2017 | $44,126 | 81 | Lumenis, Inc ($13,387) |
All Payment Transactions
368 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/27/2024 | Solta Medical, a division of Bausch Health US, LLC | Fraxel, Clear & Brilliant | Food and Beverage | In-kind items and services | $24.82 | General |
| 10/03/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1.98 | General |
| 09/25/2024 | Galderma Laboratories, L.P. | DYSPORT | Food and Beverage | In-kind items and services | $11.23 | General |
| 09/18/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $140.01 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 09/15/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $97.43 | General |
| 09/05/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $20.55 | General |
| Category: DERMATOLOGY | ||||||
| 09/05/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $19.72 | General |
| 08/08/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $24.19 | General |
| Category: FACIAL AESTHETICS | ||||||
| 07/29/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $121.74 | General |
| 07/25/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $12.38 | General |
| 07/20/2024 | Galderma Laboratories, L.P. | DYSPORT (Biological) | Food and Beverage | In-kind items and services | $68.94 | General |
| 07/11/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: FACIAL AESTHETICS | ||||||
| 07/08/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $64.48 | General |
| 06/11/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $107.07 | General |
| 06/09/2024 | Celltrion USA Inc. | ZYMFENTRA (Biological) | Education | In-kind items and services | $17.21 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/16/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $25.91 | General |
| 04/26/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $23.05 | General |
| 04/23/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $144.06 | General |
| 04/18/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $20.46 | General |
| 04/17/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $22.67 | General |
| 04/08/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $44.84 | General |
| 03/10/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $46.46 | General |
| Category: Dermatology | ||||||
| 03/08/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $31.36 | General |
| 02/24/2024 | ABBVIE INC. | BOTOX (Biological) | — | In-kind items and services | $76.42 | Research |
| Study: BOTOX (onabotulinumtoxinA) for the Reduction of Masseter Muscle Prominence: A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study • Category: FACIAL AESTHETICS | ||||||
| 02/06/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $20.67 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of EN3835 In The Treatment Of Edematous Fibrosclerotic Panniculopathy Cellulite | Endo Pharmaceuticals Inc. | $20,580 | 2 |
| Reliability and Validity of the Clinician-reported Photonumeric Cellulite Severity Scale CR-PCSS in Live Subjects | Endo Pharmaceuticals Inc. | $10,304 | 7 |
| TRALOKINUMAB CONFIRMATORY TRIAL IN ADOLESCENTS | LEO Pharma AS | $9,612 | 3 |
| A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Of EN3835 In The Treatment Of Edematous Fibrosclerotic Panniculopathy Cellulite | Endo Pharmaceuticals Inc. | $1,096 | 6 |
| EVALUATION OF EFFECTIVENESS AND SAFETY OF RADIESSE (+) FOR THE IMPROVEMENT OF JAWLINE VOLUME AND CONTOUR | MERZ NORTH AMERICA, INC. | $961.47 | 7 |
| A Multicenter, Double-Blind, Randomized, Placebo-Controlled Parallel-Group Phase 2 Study Evaluating the Safety and Efficacy of OnabotulinumtoxinA X for the Treatment of Moderate to Severe Glabellar Lines | ABBVIE INC. | $858.62 | 6 |
| BOTOX (onabotulinumtoxinA) for the Reduction of Masseter Muscle Prominence: A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study | ABBVIE INC. | $76.42 | 1 |
About Dr. Daniel Friedmann, M.D
Dr. Daniel Friedmann, M.D is a Dermatology healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/30/2008. The National Provider Identifier (NPI) number assigned to this provider is 1326200569.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Friedmann, M.D has received a total of $231,608 in payments from pharmaceutical and medical device companies, with $6,368 received in 2024. These payments were reported across 368 transactions from 25 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($77,974).
Ad
Practice Information
- Specialty Dermatology
- Other Specialties Procedural Dermatology
- Location Austin, TX
- Active Since 06/30/2008
- Last Updated 02/06/2019
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1326200569
Products in Payments
- ENSITE PRECISION (Device) $50,758
- XIAFLEX (Biological) $30,884
- XEOMIN (Biological) $7,408
- ALLODERM (Device) $6,670
- KYBELLA (Biological) $4,606
- BOTOX (Biological) $3,212
- Lumenis Pulse 120H (Device) $3,000
- M22 (Device) $3,000
- Xeomin (Biological) $2,953
- STRATTICE (Device) $600.00
- BOTOX COSMETIC (Biological) $561.98
- ONEXTON (Drug) $213.66
- Humira (Biological) $169.07
- DAXXIFY (Drug) $140.01
- AMZEEQ (Drug) $138.39
- Cordran (Drug) $131.67
- SKYRIZI (Biological) $100.57
- SILIQ (Drug) $99.77
- Otezla (Drug) $97.33
- ACZONE (Drug) $93.70
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Austin
Dr. Edward Lain, M.d, M.D
Dermatology — Payments: $2.3M
Dermatology $2.3M
Daniel Carrasco, Md, MD
Dermatology — Payments: $1.2M
Dermatology $1.2M
Dale Schaefer, Md, MD
Dermatology — Payments: $1.2M
Dermatology $1.2M
Janet Dubois, M.d, M.D
Dermatology — Payments: $1.1M
Dermatology $1.1M
Ms. Heidi Prather, M.d, M.D
Dermatology — Payments: $530,857
Dermatology $530,857
Dr. Jennifer Gordon, Md, MD
Dermatology — Payments: $161,696
Dermatology $161,696